Shuttle Pharmaceuticals Holdings, Inc. (SHPH): Depreciation & Amortization
$290.1K
Year ended 2025-12-31
$1.56M
Trailing 12 months to 2026-06-30
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $290.1K | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $5.5K | n/a | 2026-03-31, From 2024-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $290.1K | n/m |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $61.0K | +408.3% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $800.0K | +14.3% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $17.3K | 0.0% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $7.2K | +61.6% |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $72.0K | -42.9% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $55.0K | -86.7% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $24.0K | +242.9% |
| Kala Bio, Inc. (KALA) | 2025-12-31 | $317.0K | +22.4% |
Compare SHPH, TRAW, LGVN, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗